JNK inhibition reduces lung remodeling and pulmonary fibrotic systemic markers
JNK inhibition reduces lung remodeling and pulmonary fibrotic systemic markers
About this item
Full title
Author / Creator
van der Velden, Jos L. J. , Ye, Ying , Nolin, James D. , Hoffman, Sidra M. , Chapman, David G. , Lahue, Karolyn G. , Abdalla, Sarah , Chen, Peng , Liu, Yong , Bennett, Brydon , Khalil, Nasreen , Sutherland, Donna , Smith, William , Horan, Gerald , Assaf, Mahmoud , Horowitz, Zebulun , Chopra, Rajesh , Stevens, Randall M. , Palmisano, Maria , Janssen-Heininger, Yvonne M. W. and Schafer, Peter H.
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Background
Lung remodeling and pulmonary fibrosis are serious, life-threatening conditions resulting from diseases such as chronic severe asthma and idiopathic pulmonary fibrosis (IPF). Preclinical evidence suggests that JNK enzyme function is required for key steps in the pulmonary fibrotic process. However, a selective JNK inhibitor has not be...
Alternative Titles
Full title
JNK inhibition reduces lung remodeling and pulmonary fibrotic systemic markers
Authors, Artists and Contributors
Author / Creator
Ye, Ying
Nolin, James D.
Hoffman, Sidra M.
Chapman, David G.
Lahue, Karolyn G.
Abdalla, Sarah
Chen, Peng
Liu, Yong
Bennett, Brydon
Khalil, Nasreen
Sutherland, Donna
Smith, William
Horan, Gerald
Assaf, Mahmoud
Horowitz, Zebulun
Chopra, Rajesh
Stevens, Randall M.
Palmisano, Maria
Janssen-Heininger, Yvonne M. W.
Schafer, Peter H.
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5010551
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5010551
Other Identifiers
ISSN
2001-1326
E-ISSN
2001-1326
DOI
10.1186/s40169-016-0117-2
